It was shown that the CaM inhibitor trifluoperazine inhibited the adhesion of the lymphosarcoma and breast carcinoma cells to the hepatocytes, albeit more efficiently in the former cells [79], suggesting the involvement of CaM in this process. This evidence concerns the gene CALM1 and lymphoma.